NCT06386315
Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma
At risk: Primary completion moved 2 years later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 17 versions: 17 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from May 30, 2027 to May 30, 2029 Show 5 more changesShow less
- Eligibility criteria expanded, about 20 words
- Study completion pushed from May 30, 2027 to May 30, 2031
- Secondary endpoints: details revised at 3 of 3 entries
- Study description revised
- Site details revised at 1 of 7 sites
- Notable Primary and study completion dates: May 30, 2026 to May 30, 2027
- Site contacts updated at 2 of 7 sites
- Minor Study description expanded, about 1 wordv15
- Notable Eligibility criteria expanded, about 3 wordsv14
- Minor Study description expanded, about 5 wordsv13
Show 11 earlier versionsHide 11 earlier versions
- Notable Eligibility criteria shortened, about 1 wordv12
- Notable Eligibility criteria expanded, about 3 words
- Site contacts updated at 7 of 7 sites
- Minor Study description expanded, about 17 words
- Site details revised at 7 of 7 sites
- Notable Eligibility criteria expanded, about 3 words
- Study sites: 3 to 7
- Secondary endpoints: details revised at 1 of 3 entries
- Minor Site details revised at 3 of 3 sitesv8
- Minor Site details revised at 1 of 3 sitesv7
- Notable Enrollment target: 40 to 112
- Site contacts updated at 3 of 3 sites
- Notable Primary and study completion dates: May 30, 2024 to May 30, 2026v5
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of May 1, 2024 to May 15, 2024
- Site details revised at 3 of 3 sites
- Notable Enrollment target: 112 to 40v3
- Minor Secondary endpoints: details revised at 1 of 3 entriesv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (3)
Arms and interventions
Patients undergo reduced dose ISRT once daily (excluding weekends): 9 Gy delivered in 3 treatment fractions or 8 Gy in 2 fractions. At physician discretion, patients may receive 10 Gy in 5 fractions. Patients also undergo CT or PET/CT throughout the study. Patients may additionally undergo endoscopy during screening and during follow up.
Patients undergo standard of care (SOC) radiation therapy once daily (excluding weekends): 24 Gy in 12 treatment fractions. Patients also undergo CT or PET/CT throughout the study. Patients may additionally undergo endoscopy during screening and during follow up.
Procedures: Computed Tomography, Endoscopic Procedure, Positron Emission Tomography
Radiation: Involved-site Radiation Therapy (3 Fractions), Involved-site Radiation Therapy (12 Fractions)
Other: Questionnaire Administration
Sites
7 sites in 1 country